V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008707 | 280005937 | 1.7 | 49 | Palliative (P) | 2016-08-30 | 2016-09-02 | EW EuroEwing 99 : VActI | N | N | 280028558 | EURO-EWING |
| 280008708 | 280005938 | 1.74 | 91 | Palliative (P) | 2016-04-11 | 2016-04-18 | Etoposide + Ifosfamide (3 days) | 2 | N | 280028558 | ETOPOSIDE + IFOSFAMIDE |
| 280008709 | 280005939 | 1.77 | null | Palliative (P) | 2019-04-20 | 2019-05-14 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280028563 | GEMCITABINE |
| 280008710 | 280005940 | 1.61 | 81 | Palliative (P) | 2014-03-06 | 2014-03-06 | VAC | N | N | 280028563 | CAV |
| 280008711 | 280010635 | 1.6 | null | Palliative (P) | 2016-10-31 | 2016-11-04 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280028572 | DOXORUBICIN + IFOSFAMIDE |
| 280008712 | 280005941 | 1.74 | 63 | Palliative (P) | 2013-11-27 | 2014-12-18 | Cyclophosphamide oral | N | N | 280028574 | CYCLOPHOSPHAMIDE |
| 280008713 | 280009112 | 1.63 | 73.3 | Curative (C) | 2010-08-31 | 2013-07-07 | Doxorubicin + Ifosfamide | N | N | 280028575 | DOXORUBICIN + IFOSFAMIDE |
| 280008714 | 280009112 | 1.81 | 75.4 | Palliative (P) | 2015-07-27 | 2015-07-28 | Irinotecan + Temozolomide | N | N | 280028575 | IRINOTECAN + MDG |
| 280008715 | 280005944 | null | null | Palliative (P) | 2011-11-20 | 2013-02-13 | Doxorubicin + Olaratumab | 02 | N | 280028579 | DOXORUBICIN + OLARATUMAB |
| 280008716 | 280005945 | null | 31.45 | Adjuvant (A) | 2014-01-18 | 2014-01-19 | Doxorubicin + Olaratumab | N | N | 280028582 | DOXORUBICIN + OLARATUMAB |
| 280008717 | 280009115 | 1.61 | null | Palliative (P) | 2015-11-10 | 2015-12-06 | Doxorubicin + Olaratumab | N | N | 280028583 | DOXORUBICIN + OLARATUMAB |
| 280008718 | 280010637 | 1.72 | 73 | Palliative (P) | 2016-11-13 | 2016-11-14 | CISPLATIN + FLUOROURACIL | 1 | N | 280028588 | CISPLATIN + FLUOROURACIL |
| 280008719 | 280005946 | 1.81 | 119.3 | Adjuvant (A) | 2015-11-04 | 2015-12-07 | DOXORUBICIN + IFOSFAMIDE | N | N | 280028590 | DOXORUBICIN + IFOSFAMIDE |
| 280008720 | 280005947 | 1.6 | 91.7 | Palliative (P) | 2017-05-22 | 2017-06-22 | DE-ESCALATE TRIAL | Y | null | 280028590 | DE-ESCALATE TRIAL |
| 280008721 | 280005949 | null | 64.05 | Palliative (P) | 2013-09-08 | 2013-10-01 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280028593 | CARBOPLATIN + PACLITAXEL |
| 280008722 | 280005954 | 1.74 | 51.5 | Palliative (P) | 2016-03-30 | 2016-04-27 | DE-ESCALATE TRIAL | 02 | N | 280028597 | DE-ESCALATE TRIAL |
| 280008723 | 280011379 | null | 76.7 | Palliative (P) | 2014-05-27 | 2014-05-27 | Oxaliplatin + Modified de Gramont | N | null | 280028600 | OXALIPLATIN + MDG |
| 280008724 | 280005955 | null | null | Palliative (P) | 2016-05-06 | 2016-06-05 | Etoposide + Ifosfamide (3 days) | N | Y | 280028604 | ETOPOSIDE + IFOSFAMIDE |
| 280008725 | 280005956 | 1.59 | 67 | null | 2013-06-16 | 2013-06-25 | Doxorubicin + Olaratumab | 02 | N | 280028609 | DOXORUBICIN + OLARATUMAB |
| 280008726 | 280005957 | 1.8 | null | Neo-adjuvant (N) | null | 2017-10-08 | DE-ESCALATE TRIAL | null | null | 280028610 | DE-ESCALATE TRIAL |
| 280008727 | 280005959 | 1.58 | 95 | Palliative (P) | 2014-05-26 | 2014-11-17 | Doxorubicin + Ifosfamide | N | N | 280028610 | DOXORUBICIN + IFOSFAMIDE |
| 280008728 | 280010640 | 1.77 | 72.2 | Palliative (P) | 2018-02-07 | 2018-02-07 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280028629 | CISPLATIN + FLUOROURACIL |
| 280008729 | 280005961 | 1.75 | 51.1 | Palliative (P) | 2014-04-22 | 2014-05-07 | Carboplatin + Etoposide iv&po | 02 | N | 280028632 | CARBOPLATIN + ETOPOSIDE |
| 280008730 | 280005961 | 1.64 | 58.6 | Palliative (P) | 2013-09-26 | 2013-09-26 | CARBOPLATIN + PACLITAXEL | null | Y | 280028632 | CARBOPLATIN + PACLITAXEL |
| 280008731 | 280005962 | 1.88 | 73.6 | Palliative (P) | 2014-11-01 | 2014-11-01 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 280028640 | CISPLATIN + GEMCITABINE |
| 280008732 | 280005962 | 1.75 | 85.6 | Adjuvant (A) | 2015-09-12 | 2015-09-12 | CARBOPLATIN + PACLITAXEL | 02 | N | 280028640 | CARBOPLATIN + PACLITAXEL |
| 280008733 | 280005962 | 1.6 | 108.5 | Neo-adjuvant (N) | 2015-03-26 | 2015-03-26 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | Y | 280028640 | CETUXIMAB + CISPLATIN + FU |
| 280008734 | 280005964 | 1.88 | 69.2 | Curative (C) | 2016-06-20 | 2016-07-01 | VAI (Ifos 3g/m2) | N | N | 280028647 | IRINOTECAN + TEMOZOLOMIDE |
| 280008735 | 280005965 | 1.92 | 88.1 | Curative (C) | 2017-08-05 | 2017-08-23 | EW EuroEwing 99 : VIDE | N | null | 280028651 | EURO-EWING |
| 280008736 | 280009123 | 1.65 | 55.1 | Neo-adjuvant (N) | 2014-05-10 | 2014-05-31 | Gemcitabine weekly | 02 | Y | 280028652 | GEMCITABINE |
| 280008737 | 280009123 | 1.78 | 70.8 | Curative (C) | null | 2017-02-04 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 280028652 | GEMCITABINE |
| 280008738 | 280009123 | 1.74 | 65.9 | null | null | 2017-11-25 | Cisplatin +Fluorouracil (3 wk) | null | null | 280028652 | CISPLATIN + FLUOROURACIL |
| 280008739 | 280005966 | 1.82 | 78 | Palliative (P) | 2018-05-07 | 2018-05-23 | Etoposide + Ifosfamide (3 days) | Y | N | 280028662 | ETOPOSIDE + IFOSFAMIDE |
| 280008740 | 280005969 | 1.62 | null | Palliative (P) | 2016-10-26 | 2016-10-26 | Cetuximab +Cisplatin + FU (Cycle 1) | Y | null | 280028664 | CETUXIMAB + CISPLATIN + FU |
| 280008741 | 280005971 | 1.78 | 88.2 | Neo-adjuvant (N) | null | 2017-03-09 | DE-ESCALATE TRIAL | null | null | 280028666 | DE-ESCALATE TRIAL |
| 280008742 | 280005972 | 1.65 | 62.2 | null | 2014-12-02 | 2014-12-02 | Gemcitabine weekly | 02 | N | 280028667 | GEMCITABINE |
| 280008743 | 280005972 | 1.79 | 68 | Curative (C) | 2014-09-09 | 2014-09-21 | DE-ESCALATE TRIAL | N | N | 280028667 | DE-ESCALATE TRIAL |
| 280008744 | 280005973 | 1.63 | 127 | null | 2017-05-24 | 2017-05-24 | EW EuroEwing 2012 Arm A VIDE | Y | null | 280028669 | EURO-EWING |
| 280008745 | 280011382 | 1.63 | 72.4 | Palliative (P) | 2015-12-11 | 2016-01-07 | Oxaliplatin + Modified de Gramont | 2 | N | 280028670 | OXALIPLATIN + MDG |
| 280008746 | 280011930 | 1.76 | 68 | Adjuvant (A) | 2016-02-07 | 2016-02-12 | Doxorubicin + Ifosfamide | 2 | N | 280028677 | DOXORUBICIN + IFOSFAMIDE |
| 280008747 | 280011930 | 1.5 | 91 | Adjuvant (A) | 2014-06-09 | 2014-06-27 | Irinotecan + Modified De Gramont | 02 | N | 280028677 | IRINOTECAN + TEMOZOLOMIDE |
| 280008748 | 280005974 | null | 54.3 | null | 2016-11-09 | 2016-11-09 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280028681 | CARBOPLATIN + PACLITAXEL |
| 280008749 | 280005974 | 0 | 62.2 | Adjuvant (A) | 2017-11-04 | 2017-11-12 | DE-ESCALATE TRIAL | 02 | N | 280028681 | DE-ESCALATE TRIAL |
| 280008750 | 280009127 | 1.63 | null | Palliative (P) | 2014-10-26 | 2014-10-29 | Etoposide + Ifosfamide (3 days) | N | null | 280028685 | ETOPOSIDE + IFOSFAMIDE |
| 280008751 | 280009128 | null | null | Curative (C) | 2017-07-21 | 2017-08-18 | CARBOPLATIN + PACLITAXEL | 02 | null | 280028686 | CARBOPLATIN + PACLITAXEL |
| 280008752 | 280009128 | null | null | Neo-adjuvant (N) | 2013-07-12 | 2013-07-18 | Etoposide + Ifosfamide (5 days) | N | N | 280028686 | ETOPOSIDE + IFOSFAMIDE |
| 280008753 | 280005977 | 1.68 | 56.3 | Curative (C) | 2017-09-13 | 2017-09-14 | Carboplatin + Paclitaxel (weekly) | 02 | N | 280028689 | CARBOPLATIN + PACLITAXEL |
| 280008754 | 280010646 | 1.69 | 66.2 | Curative (C) | 2018-07-11 | 2018-08-05 | CYCLOPHOSPHAMIDE | N | N | 280028697 | CYCLOPHOSPHAMIDE |
| 280008755 | 280005980 | 1.53 | 82.3 | Palliative (P) | 2015-05-04 | 2015-06-21 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028697 | GEMCITABINE |
| 280008756 | 280005980 | null | null | null | null | 2015-05-10 | Doxorubicin + Ifosfamide | N | null | 280028697 | DOXORUBICIN + IFOSFAMIDE |